• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 516784 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414686638 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414686638 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Ligand Pharmaceuticals: The Winning Streak Continues (LGND)

Published on Wed, 06/12/2013 - 14:39
By Adrienne Chilton

Shares of Ligand Pharmaceuticals (NASDAQ:LGND) traded today at $32.85, breaking its 52-week high. So far today approximately 61,000 shares have been exchanged, as compared to an average 30-day volume of 224,000 shares.

In the past 52 weeks, shares of Ligand Pharmaceuticals have traded between a low of $12.30 and a high of $32.85 and are now at $31.73, which is 158% above that low price. Over the past week, the 200-day moving average (MA) has gone up 1.1% while the 50-day MA has advanced 1.2%.

Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular receptors. These receptors play a role in regulating the genetic processes affecting diseases such as gynecological disorders, certain cancers, as well as cardiovascular, inflammatory, and skin diseases.

Ligand Pharmaceuticals (NASDAQ:LGND) has potential upside of 14.1% based on a current price of $31.73 and analysts' consensus price target of $36.20. The stock should discover initial support at its 50-day moving average (MA) of $27.43 and subsequent support at its 200-day MA of $21.43.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Bullish Moving Average Cross by Acadia H...

Today, shares of Acadia Healthcare (NASDAQ:ACHC) have crossed bullishly above their 10- ...

Stock Investors Sell Off Shares of Nordi...

Nordic American Tanker Shipping (NYSE:NAT) is a company whose shares are active, tradin ...

Bearish Moving Average Cross by Teradyne...

Teradyne (NYSE:TER) shares have crossed bearishly below their 10-day moving average of ...

Shares of Linear Technology Under Pressu...

Linear Technology (NASDAQ:LLTC) is one of today's notable stocks in decline, down 1.9% ...

Crane Bullish Moving Average Crossover A...

Crane (NYSE:CR) shares have crossed bullishly above their 10-day moving average of $60. ...

Shares of Franco-Nevada Under Pressure, ...

Down 1.9% to $49.81, Franco-Nevada (NYSE:FNV), is one of today's notable movers. The S ...

Shares of BHP Billiton Under Pressure, D...

Down 1.9% to $51.31, BHP Billiton (NYSE:BBL), is one of today's notable movers. The Do ...

Bullish Moving Average Cross by Validus ...

Validus Holdings (NYSE:VR) crossed over its 10-day moving average of $39.69 on a volume ...